10q10k10q10k.net
LEMAITRE VASCULAR INC

LEMAITRE VASCULAR INCLMATEarnings & Financial Report

Nasdaq

LeMaitre Vascular is an American medical device company established in 1986 by vascular surgeon George D. LeMaitre, and based in Burlington, Massachusetts, which provides devices, implants and human tissue cryopreservation services used by surgeons in the treatment of vascular conditions, particularly peripheral vascular disease. As of 2022, LeMaitre Vascular sells directly to hospitals in 25 countries and through distributors in more than 70 countries throughout North America, Europe and Asi...

NextFeb 28, 2026

LMAT Q3 2025 Key Financial Metrics

Revenue

$61.0M

Gross Profit

$46.0M

Operating Profit

$20.3M

Net Profit

$17.4M

Gross Margin

75.3%

Operating Margin

33.3%

Net Margin

28.4%

YoY Growth

11.4%

EPS

$0.75

Financial Flow

LEMAITRE VASCULAR INC Q3 2025 Financial Summary

LEMAITRE VASCULAR INC reported revenue of $61.0M for Q3 2025, with a net profit of $17.4M (28.4% margin). Cost of goods sold was $15.1M, operating expenses totaled $25.6M.

Key Financial Metrics

Total Revenue$61.0M
Net Profit$17.4M
Gross Margin75.3%
Operating Margin33.3%
Report PeriodQ3 2025

LEMAITRE VASCULAR INC Annual Revenue by Year

LEMAITRE VASCULAR INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $219.9M).

YearAnnual Revenue
2024$219.9M
2023$193.5M
2022$161.7M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$48.9M$53.5M$55.8M$54.8M$55.7M$59.9M$64.2M$61.0M
YoY Growth19.4%13.6%11.4%15.6%14.0%12.0%15.0%11.4%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$346.8M$354.0M$363.1M$377.0M$551.8M$556.0M$577.6M$598.1M
Liabilities$48.9M$45.5M$43.5M$46.0M$214.5M$208.4M$214.9M$219.1M
Equity$297.9M$308.5M$319.5M$331.1M$337.3M$347.6M$362.7M$378.9M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$10.7M$5.1M$9.6M$14.2M$15.2M$9.0M$20.3M$28.8M